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IVUS-guided group (p0.029), resulting in significant difference in ST-elevation MI
between two groups (9.8% vs. 2.4%, p0.030).
Conclusions: IVUS-guided two-stent techniques was associated with significantly
reduced late stent thrombosis, with resultant reduction of ST-elevation myocardial
infarction.
Table 7. Clinical follow-up after propensity score matching
IVUS-guided
(n123)
Angio-guided
(n123) p
In-hospital, n (%)
Stent thrombosis 2(0.6) 5(1.6) 0.272
Overall death 1(0.3) 3(1.0) 0.359
Cardiac 1(0.3) 3(1.0) 0.359
Myocardial infarction 12(3.7) 11(3.6) 1.000
STEMI 3(0.9) 6(2.0) 0.327
CABG 0 0 NS
TLR 0 1(0.3) 0.484
TVR 0 1(0.3) 0.484
MACE 12(3.7) 11(3.6) 1.000
Procedural success, n (%) 312(96.3) 293(96.4) 1.000
At 12-month
Stent thrombosis 1(0.8) 10(8.1) 0.010
definite 1(0.8) 9(7.3) 0.019
probable 0 1(0.8) 1.000
possible 0 0 NS
early 1(0.8) 4(3.3) 0.370
late 0 6(4.9) 0.029
Overall death 0 5(4.1) 0.060
Cardiac 0 4(3.3) 0.122
Myocardial infarction 4(3.3) 12(9.8) 0.067
STEMI 3(2.4) 12(9.8) 0.030
CABG 0 1(0.8) 1.000
TLR 13(10.6) 11(11.4) 1.000
TVR 14(11.4) 17(13.8) 0.701
MACE 20(16.3) 22(17.9) 0.866
IVUS, intravascular ultrasound; STEMI, ST-segment elevation myocardial
infarction; CABG, coronary artery bypass graft; TLR, target lesion
revascularization; TVR, target vessel revascularization; MACE, major adverse
cardiac event
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Background: Emerging data suggest that 2nd generation drug-eluting stents (DES) may
improve event-free survival compared to 1st generation DES. Whether or not this applies
to both sexes is unknown.
Methods: The SPIRIT II, III and IV randomized controlled trials (RCT) compared the
second-generation everolimus-eluting stent (EES) to the first-generation paclitaxel-eluting
stent (PES). Summary-level data of each study was pooled using meta-analytic tech-
niques. We evaluated the impact of gender on adverse events stratified by DES type.
Relative risks and 95% confidence intervals were calculated for the following outcomes:
definite or probable stent thrombosis (ST), target lesion revascularization (TLR), myo-
cardial infarction (MI), major adverse cardiovascular events (MACE) and cardiac death.
Results: Women (n1583, 31.7%), were older, more often diabetic and less likely to
have multivessel disease compared to men. After a weighted mean follow-up of 2.3 years,
among patients receiving PES, the incidence of MACE was significantly higher while
rates of MI and TLR were modestly higher among women (Figure). In contrast, MACE
rates were lower with EES than PES in both men and women, and outcomes were similar
in men and women receiving EES. Rates of ST (0.5% vs. 0.7%, p0.65) and cardiac
death (0.9% vs. 1.0%, p0.95) in EES-treated patients did not differ in women vs. men.
Conclusions: In this pooled analysis of RCT, adverse events were modestly higher among
women compared to men treated with PES. In contrast, outcomes were improved with EES
in both men and women such that female sex was no longer associated greater MACE.
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Background: Quantitative evaluation of collateral flow by coronary computed tomog-
raphy angiography (CCTA) has not been reported. We did a proof-of-concept study to
determine the extent or direction of CCTA.
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